BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3263 related articles for article (PubMed ID: 27177208)

  • 41. Nitidine chloride induces apoptosis in human hepatocellular carcinoma cells through a pathway involving p53, p21, Bax and Bcl-2.
    Ou X; Lu Y; Liao L; Li D; Liu L; Liu H; Xu H
    Oncol Rep; 2015 Mar; 33(3):1264-74. PubMed ID: 25530218
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sinomenine hydrochloride inhibits human hepatocellular carcinoma cell growth in vitro and in vivo: involvement of cell cycle arrest and apoptosis induction.
    Lu XL; Zeng J; Chen YL; He PM; Wen MX; Ren MD; Hu YN; Lu GF; He SΧ
    Int J Oncol; 2013 Jan; 42(1):229-38. PubMed ID: 23165705
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways.
    Cheng P; Dai W; Wang F; Lu J; Shen M; Chen K; Li J; Zhang Y; Wang C; Yang J; Zhu R; Zhang H; Zheng Y; Guo CY; Xu L
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1162-8. PubMed ID: 24361892
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of halofuginone on the inhibition of proliferation and invasion of hepatocellular carcinoma HepG2 cell line.
    Huo S; Yu H; Li C; Zhang J; Liu T
    Int J Clin Exp Pathol; 2015; 8(12):15863-70. PubMed ID: 26884857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Growth inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is associated with down-regulation of cyclin D.
    Das SK; Hashimoto T; Kanazawa K
    Biochim Biophys Acta; 2008 Apr; 1780(4):743-9. PubMed ID: 18230364
    [TBL] [Abstract][Full Text] [Related]  

  • 46. JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell.
    Liu Z; Li G; Gou Y; Xiao D; Luo G; Saavedra JE; Liu J; Wang H
    Biomed Pharmacother; 2017 Aug; 92():989-997. PubMed ID: 28605880
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dulxanthone A induces cell cycle arrest and apoptosis via up-regulation of p53 through mitochondrial pathway in HepG2 cells.
    Tian Z; Shen J; Moseman AP; Yang Q; Yang J; Xiao P; Wu E; Kohane IS
    Int J Cancer; 2008 Jan; 122(1):31-8. PubMed ID: 17847033
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bafilomycin C1 induces G0/G1 cell-cycle arrest and mitochondrial-mediated apoptosis in human hepatocellular cancer SMMC7721 cells.
    Gao X; Han L; Ding N; Mu Y; Guan P; Hu C; Huang X
    J Antibiot (Tokyo); 2018 Sep; 71(9):808-817. PubMed ID: 29752478
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ASPP2 enhances chemotherapeutic sensitivity through the down-regulation of XIAP expression in a p53 independent manner in hepatocellular carcinoma.
    Yang T; Gao Y; Liu D; Wang Y; Wu J; Liu X; Shi Y; Chen D
    Biochem Biophys Res Commun; 2019 Jan; 508(3):769-774. PubMed ID: 30528232
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
    Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
    Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Apoptosis-inducing effect of cinobufacini on human hepatoma cell line HepG2 and its mechanism of action].
    Qi FH; Li AY; Zhao L; Zhang L; Du GH; Tang W
    Yao Xue Xue Bao; 2010 Mar; 45(3):318-23. PubMed ID: 21351507
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel all-trans retinoid acid derivative N-(3-trifluoromethyl- phenyl)- retinamide inhibits lung adenocarcinoma A549 cell migration through down-regulating expression of myosin light chain kinase.
    Fan TT; Cheng Y; Wang YF; Gui SY; Chen FH; Zhou Q; Wang Y
    Asian Pac J Cancer Prev; 2014; 15(18):7687-92. PubMed ID: 25292047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of the effects of the water-soluble total flavonoids from Isodon lophanthoides var.gerardianus (Benth.) H. Hara on apoptosis in HepG2 cell: Investigation of the most relevant mechanisms.
    Feng CP; Tang HM; Huang S; Hou SZ; Liang J; Huang W; Lai XP
    J Ethnopharmacol; 2016 Jul; 188():70-9. PubMed ID: 27132715
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Allyl-isatin suppresses cell viability, induces cell cycle arrest, and promotes cell apoptosis in hepatocellular carcinoma HepG2 cells.
    Bian W; An Y; Qu H; Yang Y; Yang J; Xu Y
    Fundam Clin Pharmacol; 2016 Jun; 30(3):253-62. PubMed ID: 26945926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. All-trans retinoic acid induces p53-depenent apoptosis in human hepatocytes by activating p14 expression via promoter hypomethylation.
    Heo SH; Kwak J; Jang KL
    Cancer Lett; 2015 Jun; 362(1):139-48. PubMed ID: 25827071
    [TBL] [Abstract][Full Text] [Related]  

  • 56. All-trans retinoic acid upregulates the expression of p53 via Axin and inhibits the proliferation of glioma cells.
    Lu J; Zhang F; Yuan Y; Ding C; Zhang L; Li Q
    Oncol Rep; 2013 Jun; 29(6):2269-74. PubMed ID: 23588680
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The retinoic acid receptor antagonist, BMS453, inhibits normal breast cell growth by inducing active TGFbeta and causing cell cycle arrest.
    Yang L; Ostrowski J; Reczek P; Brown P
    Oncogene; 2001 Nov; 20(55):8025-35. PubMed ID: 11753686
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Specific COX-2 inhibitor, meloxicam, suppresses proliferation and induces apoptosis in human HepG2 hepatocellular carcinoma cells.
    Li J; Chen X; Dong X; Xu Z; Jiang H; Sun X
    J Gastroenterol Hepatol; 2006 Dec; 21(12):1814-20. PubMed ID: 17074019
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nomad Jellyfish
    Tawfik MM; Eissa N; Althobaiti F; Fayad E; Abu Almaaty AH
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500621
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of PAK1 gene silencing on proliferation and apoptosis in hepatocellular carcinoma cell lines MHCC97-H and HepG2 and cells in xenograft tumor.
    Zhang ZL; Liu GC; Peng L; Zhang C; Jia YM; Yang WH; Mao L
    Gene Ther; 2018 Jul; 25(4):284-296. PubMed ID: 29802374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 164.